30th Sep 2020 17:56
Genedrive PLC - Manchester-based molecular diagnostics firm - Says Genedrive 96 SARS-CoV-2 Kit has received approval from the South African Health Products Regulatory Authority. Kit can now be sold within South Africa.
Chief Executive Officer David Budd says: "This is an important milestone in the commercialisation of our Covid-19 Kit in the region. South Africa is a key territory for our distributors and this approval will now provide an acceleration of commercial sales activity in the area."
Current stock price: 109.50 pence
Year-to-date change: up sharply from 22.50p at end of 2019
By Lucy Heming;Â [email protected]
Copyright 2020 Alliance News Limited. All Rights Reserved.
Related Shares:
Genedrive